When a patient's oxygen levels drop significantly, and a simple face mask isn't enough, the usual next step has traditionally been non-invasive ventilation: a tight-fitting mask strapped over the nose and mouth, connected to a machine that delivers air under pressure. It works, but patients often find it deeply uncomfortable. Talking becomes impossible. Eating is out of the question. Many patients pull the mask off repeatedly, which compromises the therapy entirely. High Flow Nasal Cannula therapy (HFNC) was developed as a better-tolerated alternative for patients who need high levels of oxygen support but aren't yet at the point of requiring a ventilator.
HFNC delivers heated, humidified oxygen through soft nasal prongs, the same type of cannula used for standard low-flow oxygen, just larger and more precisely engineered. Key differences from conventional oxygen therapy:
At these flow rates, several clinically useful things happen:
HFNC is used primarily in patients with acute hypoxaemic respiratory failure, where oxygen levels fall significantly despite conventional therapy. Common clinical situations include:
It is not appropriate for every situation. HFNC may not be suitable for patients with:
The decision is always made carefully, based on blood gas values, observed work of breathing, and the patient's clinical trajectory.
The difference in comfort is often immediately apparent. Unlike tight mask-based therapies:
Monitoring is continuous and vigilant throughout. Parameters tracked include:
If a patient is not responding within the first one to two hours, breathing effort remains high, or oxygen levels don't improve, escalation to invasive ventilation is considered promptly. A delay in recognizing HFNC failure is a known risk, and our teams are trained to identify early warning signs.
HFNC is generally well tolerated, but a few considerations are worth noting:
Most patients who respond well to HFNC improve gradually over 24 to 72 hours. Flow rates and oxygen concentration are weaned down progressively as the condition stabilizes. Compared to mask-based therapies:
This matters enormously for patient morale and cooperation during what is often a frightening period of illness.
High-flow nasal cannula oxygen therapy in Navi Mumbai at our Department of Pulmonology helps patients with acute respiratory failure. Our critical care team monitors response closely, adjusts parameters in real time, and makes timely decisions about escalation or weaning, ensuring every patient receives the right level of support at the right moment.